Azacitidine plus enasidenib improves response, but not survival, in mIDH2 AMLJune 25, 2020HematologyOncology
Subcutaneous hep A vaccination as effective as intramuscular for bleeding disorder patientsJune 12, 2020HematologyPreventive Care
Tandem transplantation, long-term maintenance may extend MM remissionJune 11, 2020HematologyOncologyMixed Topics
One-fifth of stem cell transplantation patients develop PTSDJune 9, 2020HematologyOncologyMixed Topics
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseasesJune 8, 2020DermatologyRheumatologyHematologyOncology
Acute lymphoblastic leukemia can be successfully treated in the frail elderlyJune 3, 2020GeriatricsHematologyOncology
MCC response varies based on immunosuppression type, especially CLLJune 2, 2020HematologyDermatologyOncology
Pembrolizumab prolonged PFS vs. brentuximab vedotin in r/r Hodgkin lymphomaJune 1, 2020HematologyOncology
Convalescent plasma: ‘Flavor of the month’ or valid COVID-19 treatment?May 26, 2020COVID-19 UpdatesHematology
Patient-focused precautions, testing help blunt pandemic effects on heme-onc unitMay 26, 2020COVID-19 UpdatesBreast CancerGastroenterologyMixed TopicsHematologyOncology
Inflammation, thrombosis biomarkers tied to COVID-19 deathsMay 20, 2020COVID-19 UpdatesInfectious DiseasesHematologyPulmonology
